XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Stockholders' Equity - USD ($)
Total
Cumulative Effect Period of Adoption Adjustment
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Deficit
Cumulative Effect Period of Adoption Adjustment
Total Stockholders' Equity
Total Stockholders' Equity
Cumulative Effect Period of Adoption Adjustment
Non-controlling Interest-Operating Partnership
Balance at Dec. 31, 2019 $ 1,376,749,000   $ 1,191,000 $ 1,821,810,000 $ (446,252,000)   $ 1,376,749,000    
Balance (in shares) at Dec. 31, 2019     119,096            
Net income (loss) 55,338,000       54,157,000   54,157,000   $ 1,181,000
Retirement of common stock (3,575,000)   $ (2,000) (3,573,000)     (3,575,000)    
Retirement of common stock (in shares)     (209,000)            
Dividends declared on common stock (53,415,000)       (53,415,000)   (53,415,000)    
Reductions in dividends on RSUs 27,000       27,000   27,000    
Restricted stock compensation, net of forfeitures 17,264,000     17,264,000     17,264,000    
Restricted stock grants     $ 7,000 (7,000)          
Restricted stock grants (in shares)     751,000            
Contributions to operating partnership 23,271,000               23,271,000
Distributions to non-controlling interest (1,181,000)               (1,181,000)
Balance at Dec. 31, 2020 1,413,442,000 $ (1,036,000) $ 1,196,000 1,835,494,000 (446,519,000) $ (1,036,000) 1,390,171,000 $ (1,036,000) 23,271,000
Balance (in shares) at Dec. 31, 2020     119,638            
Net income (loss) (51,896,000)       (51,896,000)   (51,896,000)    
Retirement of common stock (1,639,000)   $ (2,000) (1,637,000)     (1,639,000)    
Retirement of common stock (in shares)     (220,000)            
Dividends on RSUs (275,000)       (275,000)   (275,000)    
Restricted stock compensation, net of forfeitures 18,733,000     18,733,000     18,733,000    
Restricted stock grants     $ 9,000 (9,000)          
Restricted stock grants (in shares)     867,000            
Distributions to non-controlling interest (5,897,000)               (5,897,000)
Termination of operating partnership       17,374,000     17,374,000   $ (17,374,000)
Balance at Dec. 31, 2021 1,372,468,000   $ 1,203,000 1,869,955,000 (498,690,000)   1,372,468,000    
Balance (in shares) at Dec. 31, 2021     120,285            
Net income (loss) 122,320,000       122,320,000   122,320,000    
Retirement of common stock (79,887,000)   $ (71,000) (79,816,000)     (79,887,000)    
Retirement of common stock (in shares)     (7,141)            
Dividends on RSUs (61,000)       (61,000)   (61,000)    
Restricted stock compensation, net of forfeitures $ 17,568,000     17,568,000     17,568,000    
Restricted stock grants     $ 18,000 (18,000)          
Restricted stock grants (in shares) 1,844                
Balance at Dec. 31, 2022 $ 1,432,408,000   $ 1,150,000 $ 1,807,689,000 $ (376,431,000)   $ 1,432,408,000    
Balance (in shares) at Dec. 31, 2022     114,988